Abstract:Geometry and mechanical property have emerged as important parameters in designing nanocarriers, in addition to their size, surface charge, and hydrophilicity. However, inconsistent and even contradictory demands regarding the shape and stiffness of nanoparticles have been noted in blood circulation, tumor accumulation, and tumor cell internalization. Herein, CaCO3 nanorods (NRs) with an aspect ratio of around 2.4 are assembled with hyaluronic acid (HA) hydrogel layers to prepare CaCO3@HA NRs. The rod geometry enables lower recognition by macrophages and higher extravasation into tumor tissues than the spherical counterpart. In response to the slightly acidic tumor matrix, the acid-labile removal of CaCO3 templates achieves shape switching into spherical HA nanocapsules (NCs). The shape switchable CaCO3@HA NRs show significantly higher uptake and cytotoxicities to 4T1 cells than CaCO3-Si@HA NRs with silica layers on CaCO3 cores to inhibit shape switching. In addition, HA NCs with 2 - 8 layers of HA hydrogels exhibit stiffness from 1.85 to 12.3 N/m, and the assembly of 4 layers shows 2- to 3-fold higher cellular uptake than those of other NCs. The shape shift satisfies long-term blood circulation of NRs, and the resulting stiffness-adjustable NCs promote tissue infiltration and intracellular accommodation, resulting in a 4-fold higher drug accumulation in tumors. The CaCO3@HA NR treatment significantly suppresses tumor growth; prolongs animal survival; inhibits lung metastasis; and eliminates systemic toxicities to blood, liver, kidney, and heart tissues. This study achieves a comprehensive understanding of the shape and stiffness effects and demonstrates a hierarchical targeting strategy to address the multiple delivery barriers for chemotherapeutic agents. STATEMENT OF SIGNIFICANCE: The different barriers involved in the drug delivery pathway have inconsistent and even contradictory demands on the shape and stiffness of nanoparticles. In the current study, in situ switching of nanorods (NRs) into spherical nanocapsules (NCs) in tumor tissues is proposed to address these dilemmas. The NR shape ensures long-term blood circulation and high tumor tissue accumulation, while the in situ switching into NCs promotes tissue infiltration and cellular internalization. NCs with different numbers of hydrogel layers also provide a robust system wherein NC stiffness is controlled as a single variable to study stiffness-dependent cellular behaviors. Thus, this straightforward design offers a comprehensive understanding of how the shape and stiffness of nanocarriers affect their biological pathways.

Shape Regulated Anticancer Activities and Systematic Toxicities of Drug Nanocrystals in Vivo

In Vitro and in Vivo Anti-Tumor Efficacy of 10-Hydroxycamptothecin Polymorphic Nanoparticle Dispersions: Shape- and Polymorph-Dependent Cytotoxicity and Delivery of 10-Hydroxycamptothecin to Cancer Cells.

Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies

Shape design of high drug payload nanoparticles for more effective cancer therapy.

Drug nanocrystals for cancer therapy.

Current Progress in Cancer Treatment Using Nanomaterials

Shape Matters: Impact of Mesoporous Silica Nanoparticle Morphology on Anti-Tumor Efficacy

Nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment.

In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes

Rod-Shaped Drug Particles for Cancer Therapy: The Importance of Particle Size and Participation of Caveolae Pathway

Can the Shape of Nanoparticles Enable the Targeting to Cancer Cells over Healthy Cells?

Shape and Size Dependence of Pharmacokinetics, Biodistribution, and Toxicity of Gold Nanoparticles.

Nanomaterials for cancer therapy: current progress and perspectives

Preparation of HCPT-Loaded Nanoneedles with Pointed Ends for Highly Efficient Cancer Chemotherapy

Shape switching of CaCO3-templated nanorods into stiffness-adjustable nanocapsules to promote efficient drug delivery

In vitro/In vivo Evaluations of Hydroxyapatite Nanoparticles with Different Geometry

Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation

Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.

Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment

Functional Drug Nanocrystals for Cancer-Target Delivery

The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment